Jill M Ferdinands
Overview
Explore the profile of Jill M Ferdinands including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lewis N, Chung J, Uyeki T, Grohskopf L, Ferdinands J, Patel M
Clin Infect Dis
. 2021 Dec;
75(1):170-175.
PMID: 34875035
Background: Relative vaccine effectiveness (rVE) are metrics commonly reported to compare absolute VE (aVE) of 2 vaccine products. Methods: Estimates of rVE for enhanced influenza vaccines (eIV) vs standard inactivated...
12.
Tenforde M, Campbell A, Michaels M, Harrison C, Klein E, Englund J, et al.
J Pediatric Infect Dis Soc
. 2021 Oct;
11(1):5-8.
PMID: 34643241
At nine US hospitals that enrolled children hospitalized with acute respiratory illness (ARI) during 2015-2016 through 2017-2018 influenza seasons, 50% of children with ARI received clinician-initiated testing for influenza and...
13.
Grohskopf L, Alyanak E, Ferdinands J, Broder K, Blanton L, Talbot H, et al.
MMWR Recomm Rep
. 2021 Aug;
70(5):1-28.
PMID: 34448800
This report updates the 2020-21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8])....
14.
Ghamande S, Shaver C, Murthy K, Raiyani C, White H, Lat T, et al.
Clin Infect Dis
. 2021 Jul;
74(8):1329-1337.
PMID: 34320171
Background: Evidence for vaccine effectiveness (VE) against influenza-associated pneumonia has varied by season, location, and strain. We estimate VE against hospitalization for radiographically identified influenza-associated pneumonia during 2015-2016 to 2017-2018...
15.
Ferdinands J, Thompson M, Blanton L, Spencer S, Grant L, Fry A
Vaccine
. 2021 Jun;
39(28):3678-3695.
PMID: 34090700
The effect of influenza vaccination on influenza severity remains uncertain. We reviewed the literature for evidence to inform the question of whether influenza illness is less severe among individuals who...
16.
Talbot H, Martin E, Gaglani M, Middleton D, Ghamande S, Silveira F, et al.
Clin Infect Dis
. 2021 May;
73(12):2240-2247.
PMID: 34050659
Background: Novel coronavirus disease 2019 (COVID-19) is frequently compared with influenza. The Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) conducts studies on the etiology and characteristics of U.S. hospitalized adults...
17.
Feldstein L, Ferdinands J, Self W, Randolph A, Aboodi M, Baughman A, et al.
J Infect Dis
. 2021 May;
224(12):2035-2042.
PMID: 34013330
Background: Test-negative design studies for evaluating influenza vaccine effectiveness (VE) enroll patients with acute respiratory infection. Enrollment typically occurs before influenza status is determined, resulting in over-enrollment of influenza-negative patients....
18.
Ferdinands J, Gaglani M, Martin E, Monto A, Middleton D, Silveira F, et al.
Clin Infect Dis
. 2021 Jan;
73(4):726-729.
PMID: 33462610
We observed decreased effectiveness of influenza vaccine with increasing time since vaccination for prevention of influenza A(H3N2), influenza A(H1N1)pdm09, and influenza B/Yamagata-associated hospitalizations among adults. Maximum vaccine effectiveness (VE) was...
19.
Hughes K, Middleton D, Nowalk M, Balasubramani G, Martin E, Gaglani M, et al.
Clin Infect Dis
. 2021 Jan;
73(11):e4353-e4360.
PMID: 33388741
Background: Yearly influenza immunization is recommended for immunocompromised (IC) individuals, although immune responses are lower than that for the nonimmunocompromised and the data on vaccine effectiveness (VE) in the IC...
20.
Tenforde M, Talbot H, Trabue C, Gaglani M, McNeal T, Monto A, et al.
J Infect Dis
. 2020 Dec;
224(5):813-820.
PMID: 33378531
Background: Influenza causes significant morbidity and mortality and stresses hospital resources during periods of increased circulation. We evaluated the effectiveness of the 2019-2020 influenza vaccine against influenza-associated hospitalization in the...